small bone & joint market is highly fragmented. Orthopaedic
companies have focused almost exclusively on large bone trauma surgery
and large joint surgery. This emphasis on large bones & joints
has left the upper and lower extremities market both unconsolidated
and unfocused. Although the small bone & joint market is a significant
part of the overall orthopaedic industry, it has not attracted the
same attention that areas like total joints, spine and sports medicine
have received. SBi is totally focused on being the global product
provider in this rapidly growing market.
SBi management represents a team
with a heritage in orthopaedics and a record of proven success.
Our servant leadership culture is a key to our future success.
SBi is organized to meet the needs of surgeons. Our heritage—the
products, people and the technology—spans more than two decades
in 30 countries, but our approach to business is brand new.
Combining established companies with exciting, best in class products
and technologies, SBi is a vertically-integrated organization with
a complete product portfolio designed specifically for the small
bone & joint surgeon. Our spectrum of arthroplasty, fixation,
trauma and biologic solutions is rapidly achieving industry leadership.
We continue to expand our new product pipeline with more than 40
devices and instruments to further augment these offerings. Our
goal is to give surgeons and their patients the widest choice of
proven treatment options.
SBi was formed in May 2004 by Anthony, John and Marc Viscogliosi,
the Principals of Viscogliosi Brothers, LLC (“VB”).
Already synonymous with innovation and life-changing developments
in the musculoskeletal industry, VB now brings its vision to the
small bone & joint sector. Where they can apply their leadership
in building global orthopaedic businesses.
Alongside leading international surgeons, experienced industry
management, and far-sighted private investors, VB created SBi as
the first company to focus purely on small bone & joint science.
By bringing together established companies, talented and experienced
leaders and strong technologies, SBi now offers the broadest, most
clinically proven small bone & joint portfolio of any company
operating today. VB provides the significant capital required to
fund a company positioned for sustained growth.
This vision has been realized by the acquisition and development
of the following recognized companies (or technologies) in small
bone & joint surgery: Avanta
(hand / wrist / elbow arthroplasty and trauma products-USA); Fixano
(hand / wrist / elbow / shoulder arthroplasty and trauma products-France);
Envision (implant manufacturing-USA);
Actipore (porous metal technology-Canada); Xtremi-T
(resorbable trauma technology-USA).